Skip to main content
. 2017 Feb 28;72(9):832–839. doi: 10.1136/thoraxjnl-2016-209356

Table 4.

Convergent validity testing: Spearman's rank correlation coefficients between scales from QOL-PCD and generic HRQOL measures (SNOT-20, SGRQ-C and SF-36)

SNOT-20 SGRQ-C
SF-36
Scales of QOL-PCD Total Symptoms Activity Impacts Physical functioning Rolephysical Bodily pain General health Vitality Social functioning Role functioning Mental health Total physical score Total mental score
Physical 0.51 −0.83 −0.78 −0.85 −0.74 0.83 0.79 0.54 0.79 0.65 0.62 0.49 0.46 0.84 0.37
Emotional −0.48 −0.52 −0.04 −0.47 −0.54 0.47 0.55 0.60 0.63 0.61 0.67 0.60 0.73 0.57 0.69
Treatment −0.61 −0.67 −0.61 −0.54 −0.65 0.54 0.67 0.78 0.66 0.54 0.50 0.54 0.38 0.71 0.36
Social −0.21 −0.43 −0.40 −0.28 −0.48 0.34 0.35 0.32 0.42 0.46 0.28 0.27 0.34 0.39 0.27
Role −0.60 −0.80 −0.73 −0.67 −0.78 0.73 0.84 0.68 0.79 0.69 0.72 0.44 0.47 0.86 0.43
Health −0.64 −0.84 −0.76 −0.72 −0.84 0.71 0.79 0.76 0.87 0.79 0.76 0.50 0.62 0.87 0.56
Vitality −0.46 −0.63 −0.67 −0.49 −0.59 0.59 0.56 0.60 0.72 0.75 0.52 0.43 0.39 0.69 0.43
Upper respiratory −0.60 −0.39 −0.31 −0.31 −0.39 0.36 0.51 0.54 0.48 0.35 0.42 0.37 0.39 0.48 0.35
Lower respiratory −0.53 −0.72 −0.69 −0.61 −0.69 0.59 0.69 0.58 0.75 0.67 0.59 0.43 0.49 0.69 0.49
Ear and hearing −0.57 −0.47 −0.40 −0.36 −0.49 0.51 0.49 0.46 0.66 0.55 0.51 0.39 0.46 0.56 0.47

We a priori hypothesised scales that would have stronger correlations (closer to 1 or −1); these correlations are shadowed grey.

HRQOL, health-related quality of life;

PCD, primary ciliary dyskinesia; QOL, quality of life; SF-36, Medical Outcome Survey Short Form-36 (higher score indicates better health status); SGRQ-C, St George Respiratory Questionnaire (higher score indicates worse HRQOL).